Atlas Trials

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

Clinical trial NCT03055611 · COMPLETED

Trial details

NCT number
NCT03055611
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Study type
OBSERVATIONAL
Haemophilia AHaemophilia B
Start date
2017-05-09
Primary completion
2022-04-19
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.